BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 36836600)

  • 1. Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Jia Z; Wang S; Yan H; Cao Y; Zhang X; Wang L; Zhang Z; Lin S; Wang X; Mao J
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors and potential therapeutic targets for pulmonary hypertension.
    Yang L; Wan N; Gong F; Wang X; Feng L; Liu G
    Front Cell Dev Biol; 2023; 11():1132060. PubMed ID: 37009479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular remodeling in pulmonary hypertension.
    Tuder RM
    Cell Tissue Res; 2017 Mar; 367(3):643-649. PubMed ID: 28025704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
    Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
    Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats.
    Li T; Liu B; Li NS; Luo XJ; Peng JW; Peng J
    Life Sci; 2022 Oct; 307():120910. PubMed ID: 36029851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.
    Luo H; Liu B; Zhao L; He J; Li T; Zha L; Li X; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 Oct; 11(10):673-683.e3. PubMed ID: 28826890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).
    Li Y; Liu S; Zhang Y; Gao Q; Sun W; Fu L; Cao J
    Cardiovasc Pathol; 2018; 37():8-14. PubMed ID: 30172777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnolol alleviates hypoxia-induced pulmonary vascular remodeling through inhibition of phenotypic transformation in pulmonary arterial smooth muscle cells.
    Xiao XH; Luo FM; Wang EL; Fu MY; Li T; Jiang YP; Liu S; Peng J; Liu B
    Biomed Pharmacother; 2022 Jun; 150():113060. PubMed ID: 35658230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.
    Yu L; Hales CA
    J Vasc Res; 2011; 48(6):465-75. PubMed ID: 21691120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
    Cai D; Chen SY
    Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
    Stenmark KR; Tuder RM; El Kasmi KC
    J Appl Physiol (1985); 2015 Nov; 119(10):1164-72. PubMed ID: 25930027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
    Barman SA; Chen F; Su Y; Dimitropoulou C; Wang Y; Catravas JD; Han W; Orfi L; Szantai-Kis C; Keri G; Szabadkai I; Barabutis N; Rafikova O; Rafikov R; Black SM; Jonigk D; Giannis A; Asmis R; Stepp DW; Ramesh G; Fulton DJ
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1704-15. PubMed ID: 24947524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
    Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
    Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exosomes confer hypoxic pulmonary hypertension by transferring LOX-1 cargo to trigger phenotypic switching of pulmonary artery smooth muscle cells.
    Huang N; Wang D; Zhu TT; Ge XY; Liu H; Yao MZ; Guo YZ; Peng J; Wang Q; Zhang Z; Hu CP
    Biochem Pharmacol; 2023 Jan; 207():115350. PubMed ID: 36435201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.
    Jeffery TK; Morrell NW
    Prog Cardiovasc Dis; 2002; 45(3):173-202. PubMed ID: 12525995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Spatial Profiling Identifies Distinct Molecular Signatures of Vascular Lesions in Pulmonary Arterial Hypertension.
    Tuder RM; Gandjeva A; Williams S; Kumar S; Kheyfets VO; Hatton-Jones KM; Starr JR; Yun J; Hong J; West NP; Stenmark KR
    Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38568479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3- Mediated Transdifferentiation of Pulmonary Artery Endothelial Cells Contributes to Hypoxic Pulmonary Vascular Remodeling.
    Zhang L; Li YM; Zeng XX; Wang XY; Chen SK; Gui LX; Lin MJ
    Cell Physiol Biochem; 2018; 51(2):763-777. PubMed ID: 30463073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening.
    Liu SF; Nambiar Veetil N; Li Q; Kucherenko MM; Knosalla C; Kuebler WM
    Front Immunol; 2022; 13():959209. PubMed ID: 36275740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salusin-β, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Wang X; Chen A; Hu R; Zhang F; Liang S; Bao C; Liu X; Tang H; Han Y
    Front Pharmacol; 2022; 13():928834. PubMed ID: 36249810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.